Despite High Asthma Biologics Response Rate, Severe Disease Control Is Lacking
Asthma biologic response is high in patients with severe asthma, yet few of these patients have their severe disease under control.
Source: psychiatryadvisor.com
📰 Asthma Quality News
Asthma Quality News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Asthma Quality. Real-time updates on events, politics, business and more.
Biologics' Efficacy in Severe, Uncontrolled Asthma Associated With Higher Blood Eosinophil Count
Higher baseline blood eosinophil count was linked to improvement in asthma exacerbations and overall better outcomes seen with biologic therapies.
Source: ajmc.com
Male, female patients experience similar asthma improvements with tezepelumab
WASHINGTON — Male and female patients experienced similar improvements in their severe, uncontrolled asthma with tezepelumab over a 52-week period, according to data presented at the American Thoracic Society International Conference.“Sex-related differences in asthma prevalence and severity are well documented,” Monica Kraft, MD, Murray M. Rosenberg Professor of Medicine and
Source: healio.com
Bronchial Thermoplasty Matches Biologics for Severe Asthma
Adults with severe asthma showed similar improvements in symptoms and quality of life after treatment with BT as compared with biologics.
Khi Yung Fong National University Of Singapore National University Respiratory Medicine Asthma Control Questionnaire Asthma Quality
Source: medscape.com
Tezepelumab Significantly Benefits Severe Asthma Regardless of Patient Sex
An analysis of the phase 3 NAVIGATOR trial shows tezepelumab did not provide differing efficacy among men and women, despite historic trends of disparate severe asthma outcomes among sexes.
United States Monica Kraft International Conference American Thoracic Society Mount Sinai Health System Drug Administration
Source: hcplive.com
Number of treatable traits associated with asthma control, quality of life
The number of treatable traits patients have that do not require pharmacological care was associated with asthma control and quality of life, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.However, referrals to nonmedical professionals to treat these traits are scarce, Steffi M.J. Janssen, MSc, of the department of pulmonary rehabilitation at the
Basalt Rehabilitation Centre Clinical Immunology Asthma Control Questionnaire Asthma Quality Life Questionnaire
Source: healio.com
4D pharma Presents Late Breaking Abstract from Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma at the American Thoracic Society (ATS) 2022 International Conference
4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces
United States San Francisco Julie Seidel Biotherapeutic Mrx Neil Hunter Michelle Boxall Alex Stevenson
Source: finanznachrichten.de
4D pharma announces positive topline results from Part A of Phase I/II trial of MRx-4DP0004 for the treatment of asthma
4D pharma announces positive topline results from Part A of Phase I/II trial of MRx-4DP0004 for the treatment of asthma  Part A of the study meets primary endpoint of safety and tolerabilityAchieved multiple key secondary endpoints relating to improved asthma control compared to placeboLeeds, UK, December 13, 2...
Source: pharmiweb.com
Investegate |4d Pharma PLC Announcements | 4d Pharma PLC: 4D pharma Phase 1/2 asthma study Part A results
Investegate announcements from 4d Pharma PLC, 4D pharma Phase 1/2 asthma study Part A results
Source: investegate.co.uk
Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma
This meta-analysis of 20 randomized trials reported in 6 clinical databases compares outcomes associated with dual therapy of inhaled corticosteroids (ICS) and
United States Derekk Chu Division Of Clinical Immunology Canadian Society Of Allergy Department Of Medicine Global Initiative For Asthma
Source: jamanetwork.com